MEGHAN BROWN: Open Payments
NPI 1215435987 · MOUNT OLIVE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,865 in 118 payments from 27 companies in 2025. Trend: 2023 $2,015 · 2024 $1,833 · 2025 $1,865
Food & beverage: $1,865
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $180 |
| Novo Nordisk Inc | 12 | $179 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $160 |
| Astellas Pharma US Inc | 8 | $149 |
| Amgen Inc. | 16 | $140 |
| Aimmune Therapeutics, Inc. | 6 | $134 |
| Ardelyx, Inc. | 6 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $95 |
| ABBVIE INC. | 5 | $88 |
| PFIZER INC. | 4 | $75 |
Products named: XIFAXAN, Veozah, AIRSUPRA, ZENPEP, OTEZLA, IBSRELA, Kerendia, NURTEC ODT.
Industry payments across NC — which companies pay providers there.
